BECTON, DICKINSON AND COMPANY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Not Applicable

Completed

Conditions: Diabetes

Interventions: Device: BD Nano™ vs Nucleus
Device: NovoFine® vs Nucleus
Device: NovoTwist®/NovoFine® Plus vs Nucleus
Device: Other Commercially Available Pen Needles (Unifine® Pentips®/Mylife Clickfine®) vs Nucleus

First Posted Date: 2017-08-30

Last Posted Date: 2019-07-16

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 248

Registration Number: NCT03267264

Locations: 🇺🇸
East West Medical Research Institute, Honolulu, Hawaii, United States
🇺🇸
Rapid Medical Research, Inc., Cleveland, Ohio, United States
🇺🇸
PMG Research of Raleigh, Raleigh, North Carolina, United States

and more 1 locations

The PSIQS Study - User Experience With Pro-Set

Not Applicable

Withdrawn

Conditions: Diabetes Mellitus, Type 1

Interventions: Device: MiniMed® Pro-set®
Device: MiniMed® Quick-set®

First Posted Date: 2017-08-08

Last Posted Date: 2017-09-14

Lead Sponsor: Becton, Dickinson and Company

Registration Number: NCT03242005

Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth

Phase 2

Completed

Conditions: Preoperative Skin Preparation

Interventions: Other: Vehicle Control
Other: Saline Control
Drug: Octenidine Dihydrocloride in aqueous solution

First Posted Date: 2017-07-26

Last Posted Date: 2021-04-23

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 99

Registration Number: NCT03229759

Locations: 🇺🇸
BioScience Laboratories, Bozeman, Montana, United States

Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation

Phase 2

Completed

Conditions: Preoperative Skin Preparation

Interventions: Drug: OCT - clear
Drug: OCT- tinted
Other: ChloraPrep
Other: Saline

First Posted Date: 2017-07-21

Last Posted Date: 2021-04-23

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 131

Registration Number: NCT03224299

Locations: 🇺🇸
BioScience Laboratories, Butte, Montana, United States

Evaluating Safety and Effectiveness of Octenidine Dihydrochloride

Phase 2

Completed

Conditions: Preoperative Skin Preparation

Interventions: Drug: N,N'-(1,10-decanediyldi-1(4H)-Pyridinyl-4-ylidene)-Bis-(1-octanamine) Dihydrochloride
Drug: Placebo
Drug: Chlorhexidine gluconate

First Posted Date: 2017-05-04

Last Posted Date: 2021-08-03

Lead Sponsor: CareFusion

Target Recruit Count: 145

Registration Number: NCT03140254

Locations: 🇺🇸
BioScience Laboratories, Butte, Montana, United States

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Not Applicable

Terminated

Conditions: Uterine Cervical Neoplasm

Interventions: Procedure: Colposcopy/biopsy

First Posted Date: 2017-01-13

Last Posted Date: 2018-01-31

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 28

Registration Number: NCT03020121

Locations: 🇺🇸
American Pathology Partners Inc., Denver, Colorado, United States
🇨🇦
BioVision, Outremont, Quebec, Canada
🇺🇸
Comprehensive Clinical Trials, LLC, West Palm Beach, Florida, United States

and more 9 locations

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Device: FlowSmart Infusion Set
Device: Current Infusion Set

First Posted Date: 2016-01-26

Last Posted Date: 2017-04-13

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 75

Registration Number: NCT02662842

Locations: 🇺🇸
Atlanta Diabetes Associates, Atlanta, Georgia, United States
🇺🇸
AMCR Institute Inc., Escondido, California, United States
🇺🇸
TKL Research, Fair Lawn, New Jersey, United States

and more 1 locations

Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter

Not Applicable

Completed

Conditions: Malignant Pleural Effusion

First Posted Date: 2016-01-08

Last Posted Date: 2020-09-10

Lead Sponsor: CareFusion

Target Recruit Count: 119

Registration Number: NCT02649894

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Northwestern Unversity, Chicago, Illinois, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

and more 16 locations

Accuracy Evaluation of the BD FACS Presto System

Completed

Conditions: Acquired Immunodeficiency Syndrome

Interventions: Device: Investigational BD FACSPresto System
Device: BD FACSCalibur flow cytometer
Device: Sysmex hematology analyzer KX-21

First Posted Date: 2015-03-24

Last Posted Date: 2017-02-09

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 583

Registration Number: NCT02396355

Locations: 🇺🇸
Becton Dickinson MedLab, San Jose, California, United States
🇺🇸
San Francisco General Hospital and Trauma Center, San Francisco, California, United States
🇰🇪
KEMR/CDC Research and Public Health Collaboration, Kisumu, Kenya

and more 3 locations

Monitoring the Infusion Pressure in Insulin Infusion Sets in Healthy Adults

Completed

Conditions: Diabetes

Interventions: Device: BD Scarlett Infusion set
Device: Medtronic QuickSet Infusion Set

First Posted Date: 2015-03-06

Last Posted Date: 2017-02-09

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 60

Registration Number: NCT02382536

Locations: 🇺🇸
TKL Research, Fair Lawn, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy